title: [Diagnosis of early cancer with positron emission tomography].
abstract: PET using 18F-fluorodeoxyglucose(FDG) or 11C-L-methionine(Met) enables cancer diagnosis based on higher metabolic demand of malignant tumor. PET using FDG or Met is useful for differential diagnosis or staging of early cancer in lung mediastinum, brain, head and neck, breast, adrenal, pancreas, and others. Whole-body FDG-PET is especially useful for the detection of unexpected distant metastasis. PET can provide useful information to improve patient management in oncology.
authors.affiliation: Department of Nuclear Medicine and Radiology, Tohoku University.
authors.forename: K
authors.initials: K
authors.lastname: Kubota
mesh_terms: D002250:Carbon Radioisotopes; D003847:Deoxyglucose / Q000031:analogs & derivatives; D003937:Diagnosis, Differential; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D008479:Mediastinal Neoplasms / Q000000981:diagnostic imaging*; D008715:Methionine; D014055:Tomography, Emission-Computed
chemical_list: D002250:Carbon Radioisotopes; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose; D008715:Methionine